David Valcárcel

David Valcárcel

UNVERIFIED PROFILE

Are you David Valcárcel?   Register this Author

Register author
David Valcárcel

David Valcárcel

Publications by authors named "David Valcárcel"

Are you David Valcárcel?   Register this Author

84Publications

3015Reads

28Profile Views

Prospective Randomized Study Comparing Myeloablative Unrelated Umbilical Cord Blood Transplantation versus HLA-Haploidentical Related Stem Cell Transplantation for Adults with Hematologic Malignancies.

Biol Blood Marrow Transplant 2019 Oct 23. Epub 2019 Oct 23.

Hematology Department, Hospital Universitari i Politecnic La Fe, Instituto de Investigación Sanitaria La Fe, Valencia, Spain; Centro de Investigación Biomédica en Red de Cancer, Instituto Carlos III, Madrid, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2019.10.014DOI Listing
October 2019

Donor lymphocyte infusion for BK virus hemorrhagic cystitis and nephropathy: a case report.

Bone Marrow Transplant 2019 May 5;54(5):772-774. Epub 2018 Dec 5.

Hematology Department. Hospital Universitari Vall d'Hebron, VHIO, Departament de Medicina. Universitat Autònoma de Barcelona, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/s41409-018-0402-3
Publisher Site
http://dx.doi.org/10.1038/s41409-018-0402-3DOI Listing
May 2019

Effect of Sirolimus Exposure on the Need for Preemptive Antiviral Therapy for Cytomeglovirus Infection after Allogeneic Hematopoietic Stem Cell Transplantation.

Biol Blood Marrow Transplant 2019 05 10;25(5):1022-1030. Epub 2019 Jan 10.

Department of Hematology, Hospital Universitari i Politècnic la Fe, Valencia. Spain; Centro de Investigación Biomédica en Red Cáncer, Instituto Carlos III, Madrid, Spain. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2019.01.012DOI Listing
May 2019

Thrombotic thrombocytopenic purpura relapse induced by acute hepatitis E transmitted by cryosupernatant plasma and successfully controlled with ribavirin.

Transfusion 2018 11 4;58(11):2501-2505. Epub 2018 Oct 4.

Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, Madrid, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/trf.14831DOI Listing
November 2018

Usefulness of thrombopoietin receptor agonists for persistent clinically relevant thrombocytopenia after allogeneic stem cell transplantation.

Eur J Haematol 2018 Sep 3;101(3):407-414. Epub 2018 Aug 3.

Hematology Department, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute (IIB Sant-Pau) and José Carreras Leukemia Research Institute, Autonomous University of Barcelona (UAB), Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ejh.13132DOI Listing
September 2018

Autoimmune disorders are common in myelodysplastic syndrome patients and confer an adverse impact on outcomes.

Ann Hematol 2018 Aug 23;97(8):1349-1356. Epub 2018 Mar 23.

Department of Hematology, University Hospital Vall d'Hebron, University Autònoma of Barcelona (UAB), Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00277-018-3302-0DOI Listing
August 2018

Do Patients and Physicians Agree When They Assess Quality of Life?

Biol Blood Marrow Transplant 2017 Jun 10;23(6):1005-1010. Epub 2017 Mar 10.

Hematology Department, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain; IIB-Sant Pau, Jose Carreras Leukemia Research Institute, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2017.03.015DOI Listing
June 2017

Donor lymphocyte infusions in AML and MDS: Enhancing the graft-versus-leukemia effect.

Exp Hematol 2017 04 24;48:1-11. Epub 2016 Dec 24.

Hematopoietic Cell Transplant Program, Department of Hematology, Vall d'Hebron University Hospital, Barcelona, Spain.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S0301472X163077
Publisher Site
http://dx.doi.org/10.1016/j.exphem.2016.12.004DOI Listing
April 2017

Calreticulin mutations are exceedingly rare in patients with myelodysplastic syndromes with myelofibrosis.

Ann Hematol 2017 Feb 12;96(2):317-318. Epub 2016 Oct 12.

Servicio de Hematología, Hospital Universitario de León, León, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00277-016-2849-xDOI Listing
February 2017

Imported Disease Screening Prior to Chemotherapy and Bone Marrow Transplantation for Oncohematological Malignancies.

Am J Trop Med Hyg 2016 Dec 17;95(6):1463-1468. Epub 2016 Oct 17.

Infectious Disease Department, Vall d'Hebron University Hospital, PROSICS Barcelona, Universitat Autònoma de Barcelona, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4269/ajtmh.16-0458DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5154468PMC
December 2016

Scoring System Prognostic of Outcome in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndrome.

J Clin Oncol 2016 06 4;34(16):1864-71. Epub 2016 Apr 4.

Brian C. Shaffer and Martin Tallman, Memorial Sloan Kettering Cancer Center; Adriana K. Malone, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai; Ran Reshef, Columbia University Medical Center, New York; Mark Litzow, Mayo Clinic Rochester; Jane Liesveld, University of Rochester Medical Center, Rochester; Peter H. Wiernik, Our Lady of Mercy Medical Center, Bronx, NY; Kwang Woo Ahn, Zhen-Huan Hu, and Wael Saber, Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, WI; Taiga Nishihori and Mohamed A. Kharfan-Dabaja, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL; David Valcárcel, Hospital Vall d'Hebron, Barcelona, Spain; Michael R. Grunwald, Omotayo Fasan, and Edward Copelan, Levine Cancer Institute, Carolinas HealthCare System, Charlotte; William Allen Wood, University of North Carolina at Chapel Hill, Chapel Hill; David A. Rizzieri, Duke University Medical Center, Durham, NC; Ulrike Bacher, University of Medicine Göttingen, Göttingen, Germany; Betty Hamilton and Aaron Gerds, Cleveland Clinic Taussig Cancer Institute; Matt Kalaycio and Ron Sobecks, Cleveland Clinic Foundation, Cleveland; Basem William, Ohio State University Medical Center, Columbus, OH; Ayman Saad and Luciano J. Costa, University of Alabama at Birmingham, Birmingham, AL; Corey Cutler and Edwin Alyea, Dana-Farber Cancer Institute, Boston, MA; Erica Warlick and Celalettin Ustun, University of Minnesota Medical Center, Minneapolis, MN; Baldeep Mona Wirk, Seattle Cancer Care Alliance, Seattle, WA; Mitchell Sabloff, University of Ottawa and Ottawa Hospital Research Institute, Ottawa, Ontario; Andrew Daly, Tom Baker Cancer Center, Calgary, Alberta, Canada; David Marks, University Hospitals Bristol National Health Service Trust, Bristol; Robert Peter Gale, Imperial College London, London, United Kingdom; Richard Olsson, Karolinska Institutet, Stockholm, Sweden; Alan M. Miller, Baylor University Medical Center; Rammurti Kamble

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.65.0515DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4966345PMC
June 2016

[Bacteraemia and infection of the vascular catheter in the haematology patient: positioning and management based on the Delphi method].

Rev Esp Quimioter 2016 Feb 15;29(1):15-24. Epub 2016 Feb 15.

José Ramón Azanza Perea. Clínica Universidad de Navarra. Navarra; Dirección Avda Pío XII 36., Navarra, Spain.

View Article

Download full-text PDF

Source
February 2016

[Cost-per-responder analysis comparing romiplostim to rituximab in the treatment of adult primary immune thrombocytopenia in Spain].

Med Clin (Barc) 2015 May 22;144(9):389-96. Epub 2014 Feb 22.

Global Health Economics, Amgen (Europe) GmbH, Zug, Suiza. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.medcli.2013.11.035DOI Listing
May 2015

[Ruxolitinib as a bridge to allogeneic hematopoietic cell transplantation in a patient with idiopathic myelofibrosis].

Med Clin (Barc) 2015 Feb 18;144(4):184-5. Epub 2014 Jun 18.

Servicio de Hematología, Hospital Universitario Vall d'Hebron, Barcelona, España.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.medcli.2014.04.006DOI Listing
February 2015

Impact of cyclosporine levels on the development of acute graft versus host disease after reduced intensity conditioning allogeneic stem cell transplantation.

Mediators Inflamm 2014 30;2014:620682. Epub 2014 Jan 30.

Hematology Department, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Banc de Sang i Teixits, Institut Josep Carreras, Mas Casanovas 90, 08025 Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2014/620682DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3929065PMC
October 2014

Low CD34 dose is associated with poor survival after reduced-intensity conditioning allogeneic transplantation for acute myeloid leukemia and myelodysplastic syndrome.

Biol Blood Marrow Transplant 2014 Sep 2;20(9):1418-25. Epub 2014 Jun 2.

Department of Medicine, Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, Wisconsin; Division of Hematology & Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2014.05.021DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4127369PMC
September 2014

5q- syndrome and multiple myeloma diagnosed simultaneously and successful treated with lenalidomide.

Leuk Res 2013 Oct 26;37(10):1248-50. Epub 2013 Jul 26.

Unidad de Citogenética Hematológica, Hospital Universitario Vall d'Hebrón, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2013.06.021DOI Listing
October 2013

[Guidelines for diagnosis, treatment and monitoring of primary immune thrombocytopenia].

Med Clin (Barc) 2012 Mar 16;138(6):261.e1-261.e17. Epub 2012 Jan 16.

Servicio de Hematología, Hospital Universitario y Politécnico La Fe, Valencia, España.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.medcli.2011.11.011DOI Listing
March 2012

Pretransplantation liver function impacts on the outcome of allogeneic hematopoietic stem cell transplantation: a study of 455 patients.

Biol Blood Marrow Transplant 2011 Nov 27;17(11):1653-61. Epub 2011 Apr 27.

Hematology Departments of Hospital de la Santa Creu i Sant Pau, Autonomous University of Barcelona and Universitat Autònoma de Barcelona, Mas Casanovas 90, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2011.04.009DOI Listing
November 2011

Mesenchymal stem cells expanded in vitro with human serum for the treatment of acute and chronic graft-versus-host disease: results of a phase I/II clinical trial.

Haematologica 2011 Jul 10;96(7):1072-6. Epub 2011 Mar 10.

Servicio de Hematología, Instituto de Biomedicina de Sevilla (IBIS) Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, Avenida Manuel Siurot s/n 41013 Sevilla, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.2010.038356DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3128230PMC
July 2011

Early and late neurological complications after reduced-intensity conditioning allogeneic stem cell transplantation.

Biol Blood Marrow Transplant 2009 Nov 1;15(11):1439-46. Epub 2009 Sep 1.

Hematology Department and Stem Cell Transplantation Program, Hospital de Santa Creu i Sant Pau, Autonomous University of Barcelona, Spain.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S108387910900342
Publisher Site
http://dx.doi.org/10.1016/j.bbmt.2009.07.013DOI Listing
November 2009

Allogeneic stem cell transplantation after reduced-intensity conditioning for acute myeloid leukaemia: impact of chronic graft-versus-host disease.

Curr Opin Oncol 2009 Jun;21 Suppl 1:S35-7

Division of Clinical Hematology, Hospital de la Sant Creu i Sant Pau, Autonomous University of Barcelona, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/01.cco.0000357474.66035.9bDOI Listing
June 2009

Alemtuzumab as treatment of steroid-refractory acute graft-versus-host disease: results of a phase II study.

Biol Blood Marrow Transplant 2009 May 9;15(5):639-42. Epub 2009 Mar 9.

Hematology Department, Hematopoietic Transplantation Unit, Institute of Hematology and Oncology, Hospital Clinic, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2009.01.014DOI Listing
May 2009

Study of kidney function impairment after reduced-intensity conditioning allogeneic hematopoietic stem cell transplantation. A single-center experience.

Biol Blood Marrow Transplant 2009 Jan;15(1):21-9

Clinical Hematology and Hematopoietic Transplantation Division, Autonomous University of Barcelona, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2008.10.011DOI Listing
January 2009

Reduced intensity conditioning for allogeneic hematopoietic stem cell transplantation in myelodysplastic syndromes and acute myelogenous leukemia.

Curr Opin Oncol 2007 Nov;19(6):660-6

Division of Clinical Hematology, Hospital de la Sant Creu i Sant Pau, Autonomous University of Barcelona, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CCO.0b013e3282f0e188DOI Listing
November 2007

Encouraging results with inolimomab (anti-IL-2 receptor) as treatment for refractory acute graft-versus-host disease.

Biol Blood Marrow Transplant 2006 Nov;12(11):1135-41

Division of Clinical Hematology, Hospital de la Santa Creu i Sant Pau, Universitat Autónoma de Barcelona, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2006.06.010DOI Listing
November 2006

Low transplant related mortality in older patients with hematologic malignancies undergoing autologous stem cell transplantation.

Haematologica 2003 Mar;88(3):300-5

Servei d'Hematologia Clínica, Hospital de la Santa Creu i Sant Pau, Antoni Maria i Claret 167, 08025 Barcelona, Spain.

View Article

Download full-text PDF

Source
March 2003